1[1]Mizutani Y, Nio Y, Yoshida O. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes [J]. Cancer, 1997;69(6):2999-3007.
3Mizutani Y,Nio Y,Yoshida O.The streptococcal preparation 0K432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes[J].Cancer,1997,69 (6):2999-3007
4Talmadeg JE, Herberman RB. The preclinical creening laboratory evaluation of immunomodulatory and the repeutic properties of biological response modifiers. Cancer Treat Rep ,1986 ,70:171.
5Katano M,Morisaki T. The past,present and future of the OK - 432 therapy for patientswith malignant effusions. Anticancer Res, 1998,18 (5) : 3917-3922.
